IRIS
SANTAMATO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3887
NA - Nord America 2853
AS - Asia 1462
AF - Africa 44
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 19
SA - Sud America 14
Totale 8299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2830
IE - Irlanda 1402
CN - Cina 966
UA - Ucraina 822
SE - Svezia 483
FR - Francia 420
IT - Italia 253
TR - Turchia 170
IN - India 164
FI - Finlandia 127
GB - Regno Unito 119
DE - Germania 103
BE - Belgio 49
PK - Pakistan 43
EG - Egitto 29
PL - Polonia 29
JP - Giappone 27
IR - Iran 20
CA - Canada 19
AU - Australia 17
EU - Europa 17
NL - Olanda 15
HK - Hong Kong 13
RU - Federazione Russa 11
TH - Thailandia 11
ES - Italia 10
MY - Malesia 10
LY - Libia 9
RO - Romania 9
SG - Singapore 9
GR - Grecia 8
CZ - Repubblica Ceca 6
SA - Arabia Saudita 5
SI - Slovenia 5
CH - Svizzera 4
CO - Colombia 4
ID - Indonesia 4
MX - Messico 4
TW - Taiwan 4
BR - Brasile 3
CL - Cile 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
IL - Israele 2
KZ - Kazakistan 2
NO - Norvegia 2
PS - Palestinian Territory 2
SC - Seychelles 2
TN - Tunisia 2
YE - Yemen 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
EC - Ecuador 1
MC - Monaco 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
VN - Vietnam 1
Totale 8299
Salva come PNG Salva come JPEG
Città #
Dublin 1401
Jacksonville 579
Dearborn 430
Chandler 391
Nyköping 339
Nanjing 275
Wilmington 168
Beijing 142
Princeton 135
Nanchang 119
San Mateo 94
Ann Arbor 82
Shenyang 56
Brussels 45
Hebei 44
Kunming 42
Tianjin 42
Des Moines 41
Helsinki 37
Boardman 34
Woodbridge 33
Jinan 29
Jiaxing 28
Changsha 27
Ningbo 26
Hangzhou 25
Foggia 23
Zhengzhou 20
Bari 18
Guangzhou 17
Hilden 17
New York 14
Kraków 13
Lanzhou 13
Los Angeles 13
Flushing 12
Houston 12
London 12
Redwood City 12
Changchun 11
Ismailia 11
Kocaeli 11
Lahore 11
Philadelphia 11
Berlin 10
Milan 10
Paris 10
San Genesio Ed Uniti 10
Rome 9
Taizhou 9
Tripoli 9
Ashburn 8
Bengaluru 8
Istanbul 8
Athens 7
Dallas 7
Faisalabad 7
Lethbridge 7
Norwalk 7
Shanghai 7
Ankara 6
Auburn Hills 6
Bangkok 6
Fuzhou 6
Hefei 6
Independence 6
Saint Petersburg 6
Al Mansurah 5
Delhi 5
Duncan 5
Las Vegas 5
Mountain View 5
New Orleans 5
Verona 5
Birmingham 4
Bloomington 4
Chicago 4
Frankfurt am Main 4
Gdansk 4
Hyderabad 4
Islamabad 4
Jeddah 4
Kuala Lumpur 4
Naples 4
Nishigaoka 4
Norwich 4
Oulu 4
Ruschlikon 4
Seattle 4
Sialkot 4
Stevenage 4
Taipei 4
Tokyo 4
Warsaw 4
Aioicho 3
Amelia 3
Austin 3
Baressa 3
Bedford 3
Bekasi 3
Totale 5223
Salva come PNG Salva come JPEG
Nome #
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial. 400
Approccio clinico e riabilitativo alla sindrome da conflitto subacromiale 142
Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review 139
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial. 123
The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. 113
VALUTAZIONE BAROPODOMETRICA IN PAZIENTI CON MORBO DI PARKINSON IN FASE INIZIALE,CONFRONTO CON GRUPPO DI CONTROLLO E E SUCCESSIVA VALUTAZIONE DOPO TRATTAMENTO RIABILITATIVO 112
Lifestyle-related factors in predementia and dementia syndromes. 107
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 104
Efficacia comparata tra laser Neodimio YAG e ultrasuoni nel trattamento della sindrome da conflitto sub acromiale 104
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. 102
L’attività fisica programmata nella prevenzione dei danni secondari nel bambino diabetico” 102
Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201 101
Botulinum toxin type A in the treatment of focal hand dystonia after surgical treatment for thumb duplication. 99
severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica 97
Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis 95
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. 94
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease. 88
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 87
SBOTE study: Extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial 84
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. 83
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. 83
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 83
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 82
L'ESERCIZIO ISOCINETICO 81
Current and emerging treatments for amyotrophic lateral sclerosis. 80
Lipoproteins, vascular-related genetic factors, and human longevity. 80
Progression to dementia in probable and possible mild cognitive impairment 80
Dietary Fatty acids, age-related cognitive decline, and mild cognitive impairment 80
Vascular risk factors, alcohol intake, and cognitive decline 79
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial. 79
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. 78
Lifestyle-related factors in predementia and dementia syndromes. 78
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 77
Effect of botulinum toxin type A andmodified constraint-induced movement therapy on motor function of upper limb inchildren with obstetrical brachial plexus palsy 77
Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome). 76
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms. 74
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 74
Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? 73
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 73
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease 72
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature 71
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. 70
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial 70
Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging 69
Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging 69
Anti-β-Amyloid Immunotherapy forAlzheimer's Disease: Focus on Bapineuzumab. 69
Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review 69
Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms 68
Higher total cholesterol, cognitive decline, and dementia. 67
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity 67
Hypertension and mild cognitive impairment subtypes 66
Lifestyle-related factors, alcohol consumption, and mild cognitive impairment 66
Accuracy of botulinum toxin type A injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: manual needle placement evaluated using ultrasonography. 66
Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging 66
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 65
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease 64
Change in Coefficient of Fatigability Following Rapid, Repetitive Movement Training in Post-Stroke Spastic Paresis: A Prospective Open-Label Observational Study 64
Tau aggregation inhibitors: The future of Alzheimers pharmacotherapy? 63
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty. 62
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults. 62
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults 62
Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia? 61
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 61
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 61
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? 60
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 60
Safety and efficacy of incobotulinumtoxin A as a potential treatment for poststroke spasticity 60
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 60
The role of the rehabilitation in subjects with Progressive Supranuclear Palsy: a narrative review 60
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 60
Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries. 59
Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches 59
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 59
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. 59
Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke. 58
Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report 58
Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study. 58
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease 58
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 58
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 58
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 57
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 56
Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial 55
Post-stroke spasticity as a condition: a new perspective on patient evaluation 55
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 55
Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study. 54
Current epidemiological approaches to the metabolic-cognitive syndrome. 53
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 53
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 53
Effect of intrathecal baclofen, botulinum toxin type A and arehabilitation programme on locomotor function after spinal cord injury: a casereport. 52
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke. 52
High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy. 52
Does Spasticity Reduction by Botulinum Toxin Type A Improve Upper Limb Functionality in Adult Post-Stroke Patients? A Systematic Review of Relevant Studies. 52
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 52
Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors. 51
Intra-articular injection of botulinum toxin type A for shoulder pain in glenohumeral osteoarthritis: A case series summary and review of the literature 51
Postural and balance disorders in patients with Parkinson's disease: A prospective open-label feasibility study with two months of action observation treatment 51
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 51
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 50
Effects of Robot-Assisted Training for the Unaffected Arm in Patients with Hemiparetic Cerebral Palsy: A Proof-of-Concept Pilot Study 50
Totale 7512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201828 0000 00 00 00028
2018/2019793 9273221 140151 20112 91344134
2019/20202004 42019914241 249278 26731 1493717318
2020/20211182 16061296 17563 166151 167145212
2021/2022682 10053232 396 1755 995746194
2022/20233159 24510088121 104205 95308 16161051720
Totale 8648